- Home
- IPI vs AVIR Comparison
IPI vs AVIR Comparison
Compare IPI & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPI
- AVIR
- Stock Information
- Founded
- IPI 2000
- AVIR 2012
- Country
- IPI United States
- AVIR United States
- Employees
- IPI N/A
- AVIR N/A
- Industry
- IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- IPI Industrials
- AVIR Health Care
- Exchange
- IPI Nasdaq
- AVIR Nasdaq
- Market Cap
- IPI 475.8M
- AVIR 273.0M
- IPO Year
- IPI 2008
- AVIR 2020
- Fundamental
- Price
- IPI $33.95
- AVIR $3.60
- Analyst Decision
- IPI Strong Sell
- AVIR Hold
- Analyst Count
- IPI 1
- AVIR 1
- Target Price
- IPI $19.00
- AVIR $6.00
- AVG Volume (30 Days)
- IPI 145.7K
- AVIR 393.3K
- Earning Date
- IPI 08-04-2025
- AVIR 08-06-2025
- Dividend Yield
- IPI N/A
- AVIR N/A
- EPS Growth
- IPI N/A
- AVIR N/A
- EPS
- IPI N/A
- AVIR N/A
- Revenue
- IPI $217,865,000.00
- AVIR N/A
- Revenue This Year
- IPI $11.06
- AVIR N/A
- Revenue Next Year
- IPI N/A
- AVIR N/A
- P/E Ratio
- IPI N/A
- AVIR N/A
- Revenue Growth
- IPI N/A
- AVIR N/A
- 52 Week Low
- IPI $20.75
- AVIR $2.46
- 52 Week High
- IPI $39.01
- AVIR $4.15
- Technical
- Relative Strength Index (RSI)
- IPI 41.61
- AVIR 67.82
- Support Level
- IPI $34.36
- AVIR $3.66
- Resistance Level
- IPI $37.84
- AVIR $3.83
- Average True Range (ATR)
- IPI 1.09
- AVIR 0.13
- MACD
- IPI -0.18
- AVIR 0.00
- Stochastic Oscillator
- IPI 17.58
- AVIR 85.11
About IPI Intrepid Potash Inc
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).